| Company | 23andMe |
|---|---|
| Date | 2024-11 |
| Industry | Healthcare |
| City | SF Bay Area |
| Country | United States |
| Employees Affected | 200 |
| % of Workforce | 40% |
| Status | Post-IPO |
| Company | 23andMe |
|---|---|
| Date | 2024-11 |
| Industry | Healthcare |
| City | SF Bay Area |
| Country | United States |
| Employees Affected | 200 |
| % of Workforce | 40% |
| Status | Post-IPO |